This new OTC policy, whichever form or shape it is currently, and I am sure you would have been consulted and given your feedback. So, if you can just share like what are the key salient points or features that are expected to or are being discussed in this OTC policy?
And in our current India portfolio, what is it that Shelcal is OTC or Shelcal is non-OTC?